BROOKS LABORATORIES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Brooks Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
14.52₹ 8.87
As on Feb 9, 2026, 4:01 PM IST
Brooks Laboratories Price Performance
Today's LowToday's High
₹62.69₹73.32
₹69.97
52 Weeks' Low52 Weeks' High
₹59.00₹165.95
₹69.97
Open Price
₹64.03
Prev. Close
₹61.10
Volume
1,09,211
Over the last 5 years, the share price of Brooks Laboratories has gained 1.97% CAGR. Over the past year, the corresponding return has been -54.54%.
Brooks Laboratories’s current P/E of 9.54x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Brooks Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Brooks Laboratories | 13.24 | -7.95 | -34.39 | -54.13 | -54.54 | -11.07 | 1.97 |
| Sun Pharmaceutical Industries | 6.87 | -4.37 | 0.70 | 6.63 | -2.57 | 19.23 | 21.85 |
| Divi's Laboratories | 1.03 | -7.91 | -8.11 | -0.27 | -0.39 | 30.55 | 10.09 |
| Torrent Pharmaceuticals | 0.97 | -2.28 | 11.69 | 11.15 | 22.66 | 37.59 | 23.72 |
| Cipla | 1.40 | -8.51 | -10.77 | -9.99 | -8.82 | 9.19 | 9.63 |
| Dr. Reddy's Laboratories | 4.42 | 2.39 | 5.56 | 5.96 | 2.55 | 12.72 | 5.55 |
| Lupin | 2.76 | -0.14 | 12.12 | 13.57 | 0.50 | 43.25 | 15.62 |
| Zydus Lifesciences | 3.99 | -0.72 | -2.46 | -2.62 | -7.38 | 24.29 | 14.23 |
| Mankind Pharma | -1.81 | -9.74 | -7.81 | -17.92 | -17.15 | 13.58 | 7.94 |
| Aurobindo Pharma | -0.91 | -2.76 | 6.97 | 12.33 | 0.80 | 42.10 | 4.65 |
| Alkem Laboratories | 1.07 | -0.98 | 1.04 | 17.54 | 11.22 | 23.21 | 14.59 |
| Biocon | 2.01 | -3.43 | -1.64 | 2.55 | -3.23 | 16.30 | -1.78 |
| Abbott India | -0.81 | -3.66 | -4.69 | -16.22 | -7.87 | 9.41 | 13.62 |
| Glenmark Pharmaceuticals | -2.23 | -6.68 | 8.65 | -4.43 | 28.04 | 71.29 | 31.42 |
| Laurus Labs | 2.09 | -12.70 | 0.28 | 17.55 | 53.63 | 43.95 | 22.52 |
| GlaxoSmithKline Pharmaceuticals | 4.74 | 2.16 | -3.07 | -6.27 | 13.91 | 26.53 | 11.47 |
| Anthem Biosciences | 12.46 | 2.67 | -3.42 | -10.30 | -7.83 | -2.68 | -1.62 |
| Ipca Laboratories | -0.97 | -3.89 | 10.08 | 4.61 | -3.40 | 19.14 | 8.42 |
| Ajanta Pharma | 2.52 | 0.03 | 13.00 | 9.11 | 6.12 | 33.94 | 18.79 |
| Gland Pharma | 2.15 | 10.35 | 1.32 | -3.67 | 24.33 | 12.94 | -4.08 |
Over the last one year, Brooks Laboratories has declined 54.54% compared to peers like Sun Pharmaceutical Industries (-2.57%), Divi's Laboratories (-0.39%), Torrent Pharmaceuticals (22.66%). From a 5 year perspective, Brooks Laboratories has underperformed peers relative to Sun Pharmaceutical Industries (21.85%) and Divi's Laboratories (10.09%).
Brooks Laboratories Financials
Brooks Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 60.82 | 61.33 |
| 10 | 61.95 | 62.49 |
| 20 | 65.41 | 66.28 |
| 50 | 80.79 | 79.08 |
| 100 | 101.36 | 95.27 |
| 200 | 122.14 | 110.95 |
Brooks Laboratories Share Holding Pattern
In the latest quarter, Brooks Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 10.38%, FII holding rose to 0.09%, and public shareholding moved down to 36.91% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Brooks Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Feb 07, 2026, 2:28 AM IST | Brooks Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, 6Th February 2026. |
| Feb 07, 2026, 2:24 AM IST | Brooks Laboratories - Financial Results For The Quarter And Nine Months Ended December 31, 2025. |
| Jan 31, 2026, 12:50 AM IST | Brooks Laboratories - Disclosure Under Regulation 30 Of SEBI (LODR) Regulation, 2015- ITAT Orders. |
| Jan 29, 2026, 11:45 PM IST | Brooks Laboratories - Board Meeting Intimation for Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Reg |
| Jan 08, 2026, 5:48 AM IST | Brooks Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
About Brooks Laboratories
Brooks Laboratories Ltd. is a Public Limited Listed company incorporated on 23/01/2002 and has its registered office in the State of Himachal Pradesh, India. Company's Corporate Identification Number(CIN) is L24232HP2002PLC000267 and registration number is 000267. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 82.56 Cr. and Equity Capital is Rs. 29.46 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressVillage Kishanpura,. Solan District Himachal Pradesh 174101
- Contact
Management
- Mr. Bhushan Singh RanaWhole Time Director
- Mr. Jitendra Pratap SinghWhole Time Director
- Mr. Durga Shankar MaityWhole Time Director
- Mr. Manav MahajanIndependent Director
- Mr. Lalit MahajanIndependent Director
- Dr. Usha SinghIndependent Director
FAQs on Brooks Laboratories Share Price
What is the share price of Brooks Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Brooks Laboratories is ₹69.97 as on Feb 09, 2026.
What kind of stock is Brooks Laboratories?
The Brooks Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Brooks Laboratories?
The market cap of Brooks Laboratories is ₹206.11 Cr as on Feb 09, 2026.
What are today's High and Low prices of Brooks Laboratories?
Today’s highest and lowest price of Brooks Laboratories are ₹73.32 and ₹62.69.
What are the 52 Week High and 52 Week Low of Brooks Laboratories?
The 52-week high/low is the highest and lowest price at which Brooks Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Brooks Laboratories is ₹165.95 and 52-week low of Brooks Laboratories is ₹59.00 as on Feb 09, 2026.
How has the Brooks Laboratories performed historically in terms of returns?
The Brooks Laboratories has shown returns of 14.52% over the past day, -7.95% for the past month, -34.39% over 3 months, -54.54% over 1 year, -11.07% across 3 years, and 1.97% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Brooks Laboratories?
P/E ratio of and PB ratio of Brooks Laboratories are 9.54 and 1.78 on Feb 09, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse